Riga, Latvia

Ivars Kalvins

This inventor holds 1 USPTO granted patent. Top assignee: Uniwersytet Jagielloński. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ivars Kalvins. Retrieved from https://idiyas.com/inventor/ivars-kalvins-9vd79zad

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ivars Kalvins: Innovator in Aromatic Sulphonamides Derivatives

Introduction

Ivars Kalvins is a notable inventor based in Riga, Latvia. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on aromatic sulphonamides derivatives. His research focuses on the synthesis and application of these compounds in modulating protein disulfide isomerase (PDI) activity.

Latest Patents

Ivars Kalvins holds a patent for "Aromatic sulphonamides derivatives that inhibit PDI A3, their synthesis and use." This invention introduces a new group of aromatic sulphonamides derivatives that serve as small molecule inhibitors of PDI A3. These compounds exhibit promising antiplatelet, antithrombotic, and anticancer activities, showcasing their potential in therapeutic applications.

Career Highlights

Kalvins is affiliated with Jagiellonian University, where he continues to advance his research in the field. His work has garnered attention for its innovative approach to addressing critical health issues through chemical synthesis and modulation of biological pathways.

Collaborations

Ivars Kalvins has collaborated with esteemed colleagues such as Stefan Chlopicki and Kamil Przyborowski. These partnerships have enriched his research endeavors and contributed to the development of impactful scientific advancements.

Conclusion

Ivars Kalvins stands out as a dedicated inventor whose work on aromatic sulphonamides derivatives has the potential to influence the medical field significantly. His innovative contributions and collaborations highlight the importance of research in developing new therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…